We previously reported that the level of IL-22 and IL-22+CD4+T cells in the peripheral circulation were significantly higher in RA patients than in healthy individuals15, which may suggest a pathogenic role of these factors, but also could be attributed to a protective response of the body to RA development. This evidence concerns the gene IL22 and rheumatoid arthritis.